Manmeet Ahluwalia, MD, MBA, chief, Solid Tumor Medical Oncology; deputy director; and chief scientific officer at Miami Cancer Institute, spoke on the short- and long-term goals for Miami Cancer Institute’s Center for Equity in Cancer Care & Research in improving minority patient enrollment in clinical trials.
Minorities are underrepresented in clinical trials that lead to FDA approval of drugs, and the Center for Equity in Cancer Care & Research aims to address this issue by building trust with patients in the community and addressing social determinants of health that impede care access, said Manmeet Ahluwalia, MD, MBA, chief; Solid Tumor Medical Oncology; deputy director; and chief scientific officer at Miami Cancer Institute.
Transcript
What short- and long-term goals does the Center for Equity in Cancer Care & Research have for improving clinical trial participation, particularly for underrepresented minority groups?
We know from various efforts that minorities are underrepresented in clinical trials that lead to FDA approval of drugs. And as we are aware, only 5% to 6% of Hispanics or African Americans participate in trials that lead to FDA approval of drugs, where 90%-plus of these patients are Caucasian in origin.
So, a big emphasis of our Center with the Hispanic patients that we see or African American patients that we see is to build trust. And for this, we are partnering up with faith-based organizations to establish grassroot levels to build trust with patients for access to clinical trials. We often get our consents translated in Spanish; a number of our patients may not be able to understand the consents in English. This is to make efforts to maximize their ability to participate in clinical trials.
We are also working on various efforts with Florida International University to implement efforts to mitigate social determinants of health, which impact the minority enrollment to clinical trials. We have partnered up recently in programs with the American Society of Clinical Oncology to learn efforts to, again, improve minority enrollment to clinical trials.
Our effort is to increase the minority enrollment to clinical trials by 50% in the next 2 to 3 years, and hopefully double in the next 5 years, as we embark in our journey to further support our patients not only in South Florida, but also the patients that we see at Baptist Health, South Florida, coming from the Caribbean, or countries in Latin America.
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen